SG/CALL/NOVO-NORDISK B/1100/0.1/18.12.26 | Real-time Boerse Frankfurt Warrants 06:50:59 2024-07-02 EDT | ||
| 2.96 EUR | -1.66% |
|
| Current month | +4.51% | ||
| 1 month | +18.97% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
| Date | Price | Change |
|---|---|---|
| 24-07-02 | 2.96 | -1.66% |
| 24-07-01 | 3.01 | +4.51% |
| 24-06-28 | 2.88 | -2.70% |
| 24-06-27 | 2.96 | 0.00% |
| 24-06-26 | 2.96 | -4.21% |
Real-time Boerse Frankfurt Warrants
Last update July 02, 2024 at 06:50 am
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | 
Société Générale
|
| WKN | SU9CWC |
| ISIN | DE000SU9CWC0 |
| Date issued | 2024-02-14 |
| Strike | 1,100 kr |
| Maturity | 2026-12-18 (900 Days) |
| Parity | 10 : 1 |
| Emission price | 2.17 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.15 € |
|---|---|
| Lowest since issue | 1.99 € |
| Delta | 0x |
| Omega | 0.000000 |
| Premium | 0x |
| Gearing | 4.46x |
| Moneyness | 0.9196 |
| Difference Strike | 99.4 kr |
| Difference Strike % | +9.04% |
| Spread | 0.03 € |
| Spread % | 0.98% |
| Intrinsic value | 0.000000 |
| Present value | 3.015 |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,005
DKK
Average target price
952.2
DKK
Spread / Average Target
-5.22%
- Stock Market
- Warrants
- Warrant
